Bellini renal cell carcinoma. Diagnosis and treatment.

被引:0
|
作者
Roupret, M [1 ]
Peyromaure, M [1 ]
Hupertan, V [1 ]
Larousserie, F [1 ]
Viellefond, A [1 ]
Thiounn, N [1 ]
Dufour, B [1 ]
Zerbib, M [1 ]
Debre, B [1 ]
Mejean, A [1 ]
机构
[1] GHU Ouest Necker Cochin, APHP, Serv Urol, Paris, France
来源
PROGRES EN UROLOGIE | 2004年 / 14卷 / 04期
关键词
renal cell carcinoma; Bellini collecting duct; metastases; poor prognosis;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Bellini renal cell carcinoma. Diagnosis and treatment. The Bellini collecting duct carcinoma is a very rare form of renal cell carcinoma (1%). It presents at the stage of metastases in the very great majority of cases. The diagnosis should be considered in patients presenting with marked deterioration of the general status and/or the presence of a very large invasive renal tumour on abdominal CT scan. The overall 2-year survival rate of Bellini carcinoma is about 20%. As the prognosis is very poor, even despite radical nephrectomy, biopsy may be performed as the first-line procedure when the diagnosis is suspected. In the case of primary metastatic Bellini carcinoma, radical nephrectomy alone appears to be useless and dangerous except for analgesic purposes or in the context of new multicentre chemotherapy protocols, combining gemcitabine and cisplatin, currently under evaluation.
引用
收藏
页码:564 / 567
页数:4
相关论文
共 50 条
  • [31] Combined immuno-chemotherapic treatment in advanced renal cell carcinoma.
    Mencoboni, M
    Bruttini, GP
    Tredici, S
    Caviglia, C
    Sanna, A
    Romero, D
    Arboscello, E
    Botta, M
    Bogliolo, G
    ANNALS OF ONCOLOGY, 2000, 11 : 33 - 33
  • [32] Active surveillance as a treatment option for metastatic or recurrent renal cell carcinoma.
    Park, Inkeun
    Lee, Jae-Lyun
    Ahn, Jin-Hee
    Jeong, In Gab
    Song, Cheryn
    Hong, Bum-Sik
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [33] Immunotherapy in metastatic renal cell carcinoma. With special regard to treatment of the elderly
    Heinzer, H
    Huland, E
    Huland, H
    UROLOGE A, 2003, 42 (11): : 1450 - 1452
  • [34] A novel strategy for axitinib dosing in the treatment of metastatic renal cell carcinoma.
    Doherty, Gary
    Lynskey, Deirdre
    Matakidou, Athena
    Fife, Kate
    Eisen, Tim
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [35] Treatment of metastatic renal cell carcinoma. Immunotherapy versus surgical removal
    Heinzer, H
    Huland, E
    Huland, H
    UROLOGE A, 2000, 39 (04): : 356 - 361
  • [36] Follicular thyroid carcinoma masquerading as renal cell carcinoma.
    Chelliah, A
    Schade, DS
    Burge, MR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S148 - S149
  • [37] Sarcomatoid renal cell carcinoma.: A rare and aggressive variation of primary renal cell carcinoma
    Bannowsky, A.
    Leuschner, I.
    Schiller, H.
    Bothe, K.
    Osmonov, D.
    Juenemann, K-P
    Hautmann, S.
    UROLOGE, 2007, 46 (04): : 406 - 411
  • [38] Cell cycle regulations in primary renal cell carcinoma.
    Mu, XC
    Hou, J
    Nazeer, T
    Ross, JS
    MODERN PATHOLOGY, 1998, 11 (01) : 90A - 90A
  • [39] Diagnosis and treatment of clear cell tubulopapillary renal cell carcinoma
    Qiu, Min
    Ma, Lulin
    Lu, Jian
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 : 55 - 55
  • [40] A brief symptom index for renal cell carcinoma.
    Eton, D. T.
    Cello, D.
    Bacik, J.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 240S - 240S